EEFTMEDIUM SIGNALFINANCIAL10-K

EEFT shows concerning financial deterioration with operating cash flow declining 24% while interest expenses surge 48%, despite asset growth.

The company appears to be experiencing margin pressure and financing stress, as evidenced by the sharp rise in interest expense alongside declining operational cash generation. The significant reduction in share buybacks suggests management is conserving cash amid tightening financial conditions.

Comparing 2026-02-26 vs 2025-02-25View on EDGAR →
FINANCIAL ANALYSIS

EEFT's financial profile shows mixed signals with total assets growing 11% but accompanied by troubling operational metrics. Operating cash flow declined sharply by 24% to $560M while interest expense surged 48% to $56M, indicating potential leverage issues or rising borrowing costs. The company reduced share buybacks by 24% and saw cash reserves fall 19%, suggesting management is prioritizing liquidity amid operational headwinds and higher financing costs.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+47.9%
$37.6M$55.6M

Interest expense surged 47.9% — significant debt increase or rising rates materially impacting earnings.

Operating Cash Flow
Cash Flow
-23.6%
$732.8M$559.8M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Share Buybacks
Cash Flow
-23.5%
$229.9M$176.0M

Buyback activity reduced 23.5% — capital being redeployed elsewhere or cash conservation underway.

Inventory
Balance Sheet
+22.5%
$78.1M$95.7M

Inventory built 22.5% — monitor whether demand supports this build or if write-downs may follow.

Current Liabilities
Balance Sheet
+19.5%
$3.2B$3.9B

Current liabilities rose 19.5% — increased short-term obligations, watch current ratio.

Cash & Equivalents
Balance Sheet
-18.7%
$1.3B$1.0B

Cash decreased 18.7% — monitor burn rate and upcoming capital needs.

SG&A Expense
P&L
+18%
$315.3M$372.2M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Accounts Receivable
Balance Sheet
+17.4%
$284.9M$334.5M

Receivables grew 17.4% — monitor days sales outstanding for collection efficiency.

Total Liabilities
Balance Sheet
+12.2%
$4.6B$5.2B

Liabilities increased 12.2% — monitor debt-to-equity ratio and interest coverage.

Total Assets
Balance Sheet
+11.2%
$5.8B$6.5B

Asset base grew 11.2% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-25
ADDED
See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
7262(b)) by the registered public accounting firm that prepared or issued its audit report.
The aggregate market value was determined based on the closing price of the Common Stock on June 30, 2025.
As of February 24, 2026 , the registrant had 39,330,671 shares of Common Stock outstanding.
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 29 Item 6.
+7 more — sign up free →
REMOVED
See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12 b- 2 of the Exchange Act.
7262 (b)) by the registered public accounting firm that prepared or issued its audit re port.
The aggregate market value was determined based on the closing price of the Common Stock on June 30, 2024 .
As of February 24, 2025 , the registrant had 43,742,542 shares of Common Stock outstanding.
Market for Registrant's Common Equity, Related Stock holder Ma tters and Issuer Purchases of Equity Securities 32 Item 6.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →